DexCom
DXCM
YETI Holdings
YETI
New Fortress Energy
NFE
Dorian LPG
LPG
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | -41.60%21.29M | 19.34%7.1M | -34.42%3.84M | -58.70%4.61M | -57.45%5.74M | -40.44%36.46M | -56.00%5.95M | -57.02%5.86M | -34.82%11.16M | -20.35%13.49M |
Selling and administrative expenses | -17.25%10.5M | -46.62%1.7M | -16.86%2.75M | -9.61%2.78M | 4.73%3.28M | -2.42%12.69M | 15.54%3.18M | 5.63%3.3M | -10.08%3.07M | -15.50%3.13M |
-General and administrative expense | -17.25%10.5M | -46.62%1.7M | -16.86%2.75M | -9.61%2.78M | 4.73%3.28M | -2.42%12.69M | 15.54%3.18M | 5.63%3.3M | -10.08%3.07M | -15.50%3.13M |
Research and development costs | -54.59%10.79M | 95.20%5.4M | -57.15%1.09M | -77.33%1.83M | -76.23%2.46M | -50.69%23.77M | -74.30%2.77M | -75.69%2.55M | -40.99%8.09M | -21.71%10.36M |
Operating profit | 41.60%-21.29M | -19.34%-7.1M | 34.42%-3.84M | 58.70%-4.61M | 57.45%-5.74M | 40.44%-36.46M | 56.00%-5.95M | 57.02%-5.86M | 34.82%-11.16M | 20.35%-13.49M |
Net non-operating interest income expense | -50.03%844K | -32.94%228K | -69.13%146K | -51.81%213K | -40.78%257K | 133.93%1.69M | 19.72%340K | 114.03%473K | 183.33%442K | 611.48%434K |
Non-operating interest income | -50.03%844K | -32.94%228K | -69.13%146K | -51.81%213K | -40.78%257K | 133.93%1.69M | 19.72%340K | 114.03%473K | 183.33%442K | 611.48%434K |
Other net income (expense) | 73.47%-950K | 114.47%125K | 93.39%-182K | -3,233.33%-900K | -89.06%7K | -214.40%-3.58M | -4.35%-864K | -737.08%-2.75M | -134.62%-27K | 206.67%64K |
Gain on sale of security | 109.14%18K | 160.10%125K | -600.00%-182K | 351.85%68K | -89.06%7K | 82.70%-197K | 74.88%-208K | 92.10%-26K | -134.62%-27K | 206.67%64K |
Special income (charges) | 71.39%-968K | --0 | --0 | ---968K | ---- | ---3.38M | ---656K | ---2.73M | --0 | ---- |
-Less:Restructuring and merger&acquisition | -71.93%968K | --0 | --0 | --968K | ---- | --3.45M | --720K | --2.73M | --0 | ---- |
-Gain on sale of property,plant,equipment | --0 | ---- | ---- | ---- | ---- | --64K | ---- | ---- | ---- | ---- |
Income before tax | 44.20%-21.4M | -4.23%-6.75M | 52.36%-3.88M | 50.71%-5.3M | 57.85%-5.48M | 37.77%-38.35M | 53.98%-6.48M | 40.74%-8.14M | 36.38%-10.74M | 23.28%-12.99M |
Income tax | 41K | -8K | 7K | 42K | 0 | 0 | 0 | 0 | ||
Net income | 44.10%-21.44M | -4.11%-6.74M | 52.27%-3.88M | 50.32%-5.34M | 57.85%-5.48M | 37.77%-38.35M | 53.98%-6.48M | 40.74%-8.14M | 36.38%-10.74M | 23.28%-12.99M |
Net income continuous Operations | 44.10%-21.44M | -4.11%-6.74M | 52.27%-3.88M | 50.32%-5.34M | 57.85%-5.48M | 37.77%-38.35M | 53.98%-6.48M | 40.74%-8.14M | 36.38%-10.74M | 23.28%-12.99M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 44.10%-21.44M | -4.11%-6.74M | 52.27%-3.88M | 50.32%-5.34M | 57.85%-5.48M | 37.77%-38.35M | 53.98%-6.48M | 40.74%-8.14M | 36.38%-10.74M | 23.28%-12.99M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 44.10%-21.44M | -4.11%-6.74M | 52.27%-3.88M | 50.32%-5.34M | 57.85%-5.48M | 37.77%-38.35M | 53.98%-6.48M | 40.74%-8.14M | 36.38%-10.74M | 23.28%-12.99M |
Basic earnings per share | 48.64%-18.53 | 11.21%-5.23 | 54.80%-3.39 | 51.22%-5 | 60.78%-5 | 40.61%-36.08 | 57.16%-5.89 | 44.44%-7.5 | 38.81%-10.25 | 23.88%-12.75 |
Diluted earnings per share | 48.64%-18.53 | 11.21%-5.23 | 54.80%-3.39 | 51.22%-5 | 60.78%-5 | 40.61%-36.08 | 57.16%-5.89 | 44.44%-7.5 | 38.81%-10.25 | 23.88%-12.75 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |